Kathryn A. Gold
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies 20
- Oncology top 1%
- Lung Cancer Research Studies 24
- Cancer Immunotherapy and Biomarkers 12
- Colorectal Cancer Treatments and Studies 8
-
- Lung Cancer Treatments and Mutations 56
- Lung Cancer Diagnosis and Treatment 12
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 16
- Speech and Hearing top 2%
-
- Radiomics and Machine Learning in Medical Imaging 7
- Co-authors
- Edward S. KimJ. Jack LeeAlice T. ShawWilliam N. WilliamD. Ross CamidgeIgnacio I. WistubaHo‐Young LeeJianjun Zhang
- Journals
- Journal of Clinical Oncology (31 papers)SHILAP Revista de lepidopterología (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesSpainTaiwan
In The Last Decade
Kathryn A. Gold
96 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Otorhinolaryngology 420
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 463
- Speech and Hearing 146
Countries citing papers authored by Kathryn A. Gold
This map shows the geographic impact of Kathryn A. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn A. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn A. Gold more than expected).
Fields of papers citing papers by Kathryn A. Gold
This network shows the impact of papers produced by Kathryn A. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn A. Gold. The network helps show where Kathryn A. Gold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kathryn A. Gold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialbreakdown → | 2021 | 174 |
| 3 | 2020 | 14 | |
| 4 | 2020 | 3 | |
| 5 | 2019 | 41 | |
| 6 | 2018 | 1 | |
| 7 | 2017 | 10 | |
| 8 | 2017 | 20 | |
| 9 | 2017 | 17 | |
| 10 | 2017 | 1 | |
| 11 | Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancerbreakdown → | 2016 | 397 |
| 12 | 2016 | 60 | |
| 13 | 2016 | 261 | |
| 14 | Design, execution, and preliminary biomarker results from paired tumor biopsy cohorts of the AZD9291 AURA trial | 2015 | 1 |
| 15 | 2015 | 1 | |
| 16 | 2013 | 27 | |
| 17 | 2013 | 104 | |
| 18 | 2012 | 26 | |
| 19 | 2012 | 11 | |
| 20 | 2009 | 101 |
About Kathryn A. Gold
Kathryn A. Gold is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (56 papers), Lung Cancer Research Studies (24 papers), Head and Neck Cancer Studies (20 papers), Cancer Genomics and Diagnostics (16 papers), Lung Cancer Diagnosis and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). The work is most often cited by research in Otorhinolaryngology (420 citations), Oncology (2.1k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Kathryn A. Gold has collaborated with scholars based in United States, Spain and Taiwan. Frequent co-authors include Edward S. Kim, J. Jack Lee, Alice T. Shaw, William N. William, D. Ross Camidge, Ignacio I. Wistuba, Ho‐Young Lee, Jianjun Zhang, Stephen G. Swisher and Ezra E.W. Cohen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.